This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
CRA is a proud sponsor of this event.
Ashley Fraser is moderating a panel that will discuss how to “Prepare your Organization for Changes to Canada’s Drug Procurement Strategy.”
For more information on this event, click here.
As we reflect on another year in the rare disease space, we are proud of the continued growth and evolution of CRA’s rare disease capabilities and offerings....
More innovative medicines have a shorter assessment time by the CT ASMR rating achieved vs. average time from EMA approval to outcome of CT assessment Key...
CRA is a proud sponsor of the event covering market access, pricing, reimbursement, rare diseases, health technology assessments, health economics and outcomes...
CRA is a proud sponsor of the event. Kaitlyn Austin presents the session titled “Securing Insight Alignment to Drive Future-Proofed Strategies and...
